|
Seebio Biotech (Shanghai) Co., Ltd., stands out as one of the top suppliers of Vitamin K2 (menaquinone). Founded in 2003, Seebio initially focused on being a local manufacturer of IVD raw materials. In early 2021, Seebio entered a pivotal phase of growth with its relocation to Chuansha Smart International Industrial Park. Subsequently, in 2023, Seebio Bio-Pharmaceutical Industrial Park project in Hubei marked a significant expansion. As a global integrated service provider specializing in IVD raw materials, biochemical reagents, food ingredients, pharmaceutical excipients, medical aesthetics ingredients, natural extracts, as well as instruments and consumables, Seebio is winning customers' recognition through high quality and excellent service.
Seebio is deeply involved in the field of life sciences, offering consistent raw material support for IVD, biopharmaceutical research and development, and industrial needs. Our diverse product range includes biochemical, immunological, molecular, blood, and microbial diagnostics, along with Point of Care Testing (POCT), and specialized raw materials tailored for the biopharmaceutical industry. Seebio places a high priority on developing high-quality innovative products and offering customized services. We have established innovative technology platforms such as protein expression and purification, polyethylene glycol, and derivative technologies. Seebio focuses on biological reagents and essential biopharmaceutical raw materials, actively contributing to the development of the biopharmaceutical industry, which include
To learn more about Seebio, please visit Seebio.com.
Seebio possesses its own plant, standardized warehouse and R&D laboratory.
Seebio's international trade department has built up business relationship with customers from over 55 countries or districts in the world.
Seebio's service team is efficient and sophisticated, which is consisted of experts in marketing, R&D, production, logistics and customer service. 85% of Seebio's staff are bachelor degree or above.
The Seebio Bio-Pharmaceutical Industrial Park project in Hubei achieves large-scale production and market launch of biologically synthesized proteins, functional sugars, vitamins, functional food ingredients, organic acids, and more. We will strengthen collaboration with academic institutions, including renowned universities in East China, research institutions, the Shanghai Research Center, and pilot platforms, using a "school-enterprise synergy" approach. This collaboration aims to enhance Seebio's market competitiveness and ability to translate research findings into industrial applications in synthetic biology, chemical synthesis, and raw material formulation across 3 industrial platforms.
About Allinno
Allinno, a subsidiary of Seebio, serves as the holding brand responsible for overseeing and managing operations in the international markets. With a commitment to excellence, Allinno plays a vital role in expanding Seebio's presence beyond domestic boundaries. Leveraging its expertise and strategic approach, Allinno navigates the complexities of the global market to drive success and establish a strong international footprint for Seebio.
|